Impact of sodium-glucose cotransporter-2 inhibitors on aging biomarkers and plasma ceramide levels in type 2 diabetes: beyond glycemic control

Impact of sodium-glucose cotransporter-2 inhibitors on aging biomarkers and plasma ceramide levels in type 2 diabetes: beyond glycemic control

Background Aging is a complex biological process marked by the decline of physiological functions and heightened susceptibility to chronic illnesses, notably cardiometabolic disorders. Ceramides (Cer) are lipid derivatives linked to aging and metabolic diseases. Sodium-Glucose Cotransporter-2 inhibi...

Full description

Saved in:
Bibliographic Details
Main Authors: Youssef M. Shalaby, Mohammed Moutaz Nakhal, Bachar Afandi, Bashar Al-Zohily, Lina Majed, Kukkala Kiran Kumar, Bright Starling Emerald, Bassem Sadek, Amal Akour, Nadia Akawi
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Annals of Medicine
Subjects:
Aging biomarkers
ceramide
cardiometabolic diseases
SGLT2i
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2025.2496795
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items